Deciphering the fine details of C1 assembly and activation mechanisms: "Mission impossible"?

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Gaboriaud, Christine ^a,b,c   Ling, Wai Li ^a,b,c   Thielens, Nicole M ^a,b,c   Bally, Isabelle ^a,b,c   Rossi, Véronique ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c CEA GRENOBLE   (France)

Author keywords

C1 complex; C1q; C1r; C1s; Classical complement pathway; Complement dependent cytotoxicity; Serine protease activation; X ray structures

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; ELECTRON MICROSCOPY; GENE MUTATION; MASS SPECTROMETRY; PROTEIN ASSEMBLY; PROTEIN INTERACTION; PROTEIN STRUCTURE; SHEAR STRESS; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SURFACE PLASMON RESONANCE;

EID: 84919433309     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00565     Document Type: Article

References (54)

1. Porter RR, Reid KB. The biochemistry of complement. Nature (1978) 275:699-704. doi: 10.1038/275699a0
2. Ziccardi RJ, Cooper NR. Direct demonstration and quantitation of the first complement component in human serum. Science (1978) 199:1080-2. doi:10.1126/science.75568
3. Arlaud GJ, Colomb MG, Gagnon J. A functional model of the human C1 complex: emergence of a functional model. Immunol Today (1987) 8:106-11. doi:10.1016/0167-5699(87)90860-7
4. Gaboriaud C, Rossi V, Bally I, Arlaud GJ, Fontecilla-Camps JC. Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle. EMBO J (2000) 19:1755-65. doi:10.1093/emboj/19.8.1755
5. Venkatraman Girija U, Gingras AR, Marshall JE, Panchal R, Sheikh MA, Gal P, et al. Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation. Proc Natl Acad Sci U S A (2013) 110:13916-20. doi:10.1073/pnas.1311113110
6. Garlatti V, Chouquet A, Lunardi T, Vivès R, Païdassi H, Lortat-Jacob H, et al. Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain. J Immunol (2010) 185:808-12.
7. Brier S, Pflieger D, Le Mignon M, Bally I, Gaboriaud C, Arlaud GJ, et al. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex. J Biol Chem (2010) 285:32251-63. doi:10.1074/jbc. M110.149112
8. Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science (2014) 343:1260-3. doi:10.1126/science.1248943
9. Arkwright PD, Riley P, Hughes SM, Alachkar H, Wynn RF. Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation. J Allergy Clin Immunol (2014) 133:265-7. doi:10.1016/j.jaci.2013.07.035
10. Walport MJ. Complement. First of two parts. N Engl J Med (2001) 344:1058-66. doi:10.1056/NEJM200104053441406
11. Walport MJ. Complement. Second of two parts. N Engl J Med (2001) 344:1140-4. doi:10.1056/NEJM200104123441506
12. Roumenina LT, Sene D, Radanova M, Blouin J, Halbwachs-Mecarelli L, Dragon-Durey M-A, et al. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J Immunol (2011) 187:4369-73. doi:10.4049/jimmunol.1101749
13. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology (2002) 205:395-406. doi:10.1078/0171-2985-00141
14. Pondman KM, Sobik M, Nayak A, Tsolaki AG, Jäkel A, Flahaut E, et al. Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages. Nanomed Nanotechnol Biol Med (2014) 10:1287-99. doi:10.1016/j.nano.2014.02.010
15. Ling WL, Biro A, Bally I, Tacnet P, Deniaud A, Doris E, et al. Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. ACS Nano (2011) 5:730-7. doi:10.1021/nn102400w
16. Carroll S, Georgiou G. Antibody-mediates inhibition of human C1s and the classical complement pathway. Immunobiology (2013) 218:1041-8. doi:10.1016/j.imbio.2013.01.001
17. Leslie M. Immunology. The new view of complement. Science (2012) 337:1034-7. doi:10.1126/science.337.6098.1034
18. Daha MR. Grand challenges in molecular innate immunity. Front Immunol (2011) 2:16. doi:10.3389/fimmu.2011.00016
19. Schumaker VN, Zavodszky P, Poon PH. Activation of the first component of complement. Annu Rev Immunol (1987) 5:21-42. doi:10.1146/annurev.iy.05.040187.000321
20. Pflieger D, Przybylski C, Gonnet F, Le Caer J-P, Lunardi T, Arlaud GJ, et al. Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites. Mol Cell Proteomics (2010) 9:593-610. doi:10.1074/mcp. M900350-MCP200
21. Villiers CL, Arlaud GJ, Colomb MG. Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement. Proc Natl Acad Sci U S A (1985) 82:4477-81. doi:10.1073/pnas.82.13.4477
22. Strang CJ, Siegel RC, Phillips ML, Poon PH, Schumaker VN. Ultrastructure of the first component of human complement: electron microscopy of the crosslinked complex. Proc Natl Acad Sci U S A (1982) 79:586-90. doi:10.1073/pnas.79.2.586
23. Tschopp J, Villiger W, Fuchs H, Kilchherr E, Engel J. Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies. Proc Natl Acad Sci U S A (1980) 77:7014-8. doi:10.1073/pnas.77.12.7014
24. Poon PH, Schumaker VN, Phillips ML, Strang CJ. Conformation and restricted segmental flexibility of C1, the first component of human complement. J Mol Biol (1983) 168:563-77. doi:10.1016/S0022-2836(83)80302-7
25. Perkins SJ, Villiers CL, Arlaud GJ, Boyd J, Burton DR, Colomb MG, et al. Neutron scattering studies of subcomponent C1q of first component C1 of human complement and its association with subunit C1r2C1s2 within C1. J Mol Biol (1984) 179:547-57. doi:10.1016/0022-2836(84)90079-2
26. Weiss V, Fauser C, Engel J. Functional model of subcomponent C1 of human complement. J Mol Biol (1986) 189:573-81. doi:10.1016/0022-2836(86)90325-6
27. Davis AE, Lu F, Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost (2010) 104:886-93. doi:10.1160/TH10-01-0073
28. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, et al. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol (2000) 164:4178-84. doi:10.4049/jimmunol.164.8.4178
29. Moore GL, Chen H, Karki S, Lazar GA. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs (2010) 2:181-9. doi:10.4161/mabs.2.2.11158
30. Kellner C, Derer S, Valerius T, Peipp M. Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions. Methods (2014) 65:105-13. doi:10.1016/j.ymeth.2013.06.036
31. Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, et al. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations. Methods (2014) 65:114-26. doi:10.1016/j.ymeth.2013.06.035
32. Davies AM, Jefferis R, Sutton BJ. Crystal structure of deglycosylated human IgG4-Fc. Mol Immunol (2014) 62:46-53. doi:10.1016/j.molimm.2014.05.015
33. Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V, Bersch B, Hernandez JF, et al. Structural biology of C1: dissection of a complex molecular machinery. Immunol Rev (2001) 180:136-45. doi:10.1034/j.1600-065X.2001.1800112.x
34. Gaboriaud C, Juanhuix J, Gruez A, Lacroix M, Darnault C, Pignol D, et al. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem (2003) 278:46974-82. doi:10.1074/jbc. M307764200
35. Gaboriaud C, Frachet P, Thielens NM, Arlaud GJ. The human c1q globular domain: structure and recognition of non-immune self ligands. Front Immunol (2011) 2:92. doi:10.3389/fimmu.2011.00092
36. Budayova-Spano M, Lacroix M, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J (2002) 21:231-9.
37. Perry AJ, Wijeyewickrema LC, Wilmann PG, Gunzburg MJ, D'Andrea L, Irving JA, et al. A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4. J Biol Chem (2013) 288:15821-9. doi:10.1074/jbc. M113.464545
38. Budayova-Spano M, Grabarse W, Thielens NM, Hillen H, Lacroix M, Schmidt M, et al. Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure (2002) 10:1509-19. doi:10.1016/S0969-2126(02)00881-X
39. Rossi V, Bally I, Thielens NM, Esser AF, Arlaud GJ. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J Biol Chem (1998) 273:1232-9. doi:10.1074/jbc.273.2.1232
40. Rossi V, Teillet F, Thielens NM, Bally I, Arlaud GJ. Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules. J Biol Chem (2005) 280:41811-8.
41. Kidmose RT, Laursen NS, Dobó J, Kjaer TR, Sirotkina S, Yatime L, et al. Structural basis for activation of the complement system by component C4 cleavage. Proc Natl Acad Sci U S A (2012) 109:15425-30.
42. Kardos J, Harmat V, Palló A, Barabás O, Szilágyi K, Gráf L, et al. Revisiting the mechanism of the autoactivation of the complement protease C1r in the C1 complex: structure of the active catalytic region of C1r. Mol Immunol (2008) 45:1752-60. doi:10.1016/j.molimm.2007.09.031
43. Arlaud GJ, Barlow PN, Gaboriaud C, Gros P, Narayana SVL. Deciphering complement mechanisms: the contributions of structural biology. Mol Immunol (2007) 44:3809-22. doi:10.1016/j.molimm.2007.06.147
44. Pozzi N, Vogt AD, Gohara DW, Di Cera E. Conformational selection in trypsin-like proteases. Curr Opin Struct Biol (2012) 22:421-31. doi:10.1016/j.sbi.2012.05.006
45. Gregory LA, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, Gaboriaud C. X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. J Biol Chem (2003) 278:32157-64. doi:10.1074/jbc. M305175200
46. Gaboriaud C, Gregory-Pauron L, Teillet F, Thielens NM, Bally I, Arlaud GJ. Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions. Biochem J (2011) 439:185-93. doi:10.1042/BJ20111027
47. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol (2004) 25:368-73. doi:10.1016/j.it.2004.04.008
48. Bally I, Rossi V, Lunardi T, Thielens NM, Gaboriaud C, Arlaud GJ. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J Biol Chem (2009) 284:19340-8. doi:10.1074/jbc. M109.004473
49. Major B, Kardos J, Kekesi KA, Lorincz Z, Zavodszky P, Gal P. Calcium-dependent conformational flexibility of a CUB domain controls activation of the complement serine protease C1r. J Biol Chem (2010) 285:11863-9. doi:10.1074/jbc. M109.098541
50. Bally I, Ancelet S, Moriscot C, Gonnet F, Mantovani A, Daniel R, et al. Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites. Proc Natl Acad Sci U S A (2013) 110:8650-5. doi:10.1073/pnas.1304894110
51. Wallis R, Mitchell DA, Schmid R, Schwaeble WJ, Keeble AH. Paths reunited: initiation of the classical and lectin pathways of complement activation. Immunobiology (2010) 215:1-11. doi:10.1016/j.imbio.2009.08.006
52. Kjaer TR, Thiel S, Andersen GR. Toward a structure-based comprehension of the lectin pathway of complement. Mol Immunol (2013) 56:413-22. doi:10.1016/j.molimm.2013.05.007
53. Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol (2010) 47:2170-5. doi:10.1016/j.molimm.2010.05.009
54. Bersch B, Hernandez JF, Marion D, Arlaud GJ. Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family. Biochemistry (1998) 37:1204-14. doi:10.1021/bi971851v